New use of specific cyclolignans

Details for Australian Patent Application No. 2002311731 (hide)

International Classifications

Event Publications

2 January 2003 Complete Application Filed

Priority application(s): 0102168-2 19.06.01 SE; 60/300,431 26.06.01 SE

15 May 2003 Application Open to Public Inspection

Published as AU-B-2002311731

28 October 2004 Assignment before Grant

Axelar AB The application has been assigned to Biovitrum AB

23 March 2006 Assignment before Grant

Biovitrum AB The application has been assigned to Axelar AB

26 February 2009 Application Accepted

Published as AU-B-2002311731

14 May 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 20 Apr 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2003

3 September 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 20 Apr 2009

10 September 2009 Standard Patent Sealed

29 October 2009 Corrigenda

Applications Accepted - Name Index Under the name Axelar AB, Application No. 2002311731, Under INID correct the country to read US Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2003210817 ICAgen, Inc; Bristol-Myers Squibb Company 2003217863 Biota Scientific Management Pty Ltd 2004227266 Asahi Breweries, Ltd. 2005251829 Industrial Composites Engineering Pty Ltd 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.